[Should lipid-lowering drugs be administered to normolipemic or mild hyperlipemic patients with coronary risk factors? Arguments against].
Brotons Cuixart
C
C
Unidad de Epidemiología Clínica, Hospital Universitario Vall d'Hebron, Barcelona.
Maiques Galán
A
A
D003327:Coronary Disease / Q000209:etiology / Q000517:prevention & control*; D003362:Cost-Benefit Analysis; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D011320:Primary Health Care / Q000191:economics; D012307:Risk Factors; D012720:Severity of Illness Index
D000960:Hypolipidemic Agents
Debe administrarse terapia farmacológica hipolipemiante en normolipémicos o hiperlipémicos leves con factores de riesgo coronario? Argumentos en contra.